Moving beyond the 2018 minimum international care considerations for osteoporosis management in Duchenne muscular dystrophy (DMD): meeting report from the 3rd international muscle-bone interactions meeting 7th and 14th November 2022

Author(s):: Phung, K.; Crabtree, N.; Connolly, A.M.; Furlong, P.; Hoffman, E.P.; Jackowski, S.A.; Jayash, S.N.; Johnson, A.; Koujok, K.; Munns, C.F.; Niks, E.; Rauch, F.; Schrader, R.; Turner, C.; Vroom, E.; Weber, D.R.; Wong, B.L.; Guglieri, M.; Ward, L.M.; Wong, S.C.

Published: 2024
Publication type: Article / Letter to editor

Bisphosphonatesbone densityglucocorticoidvertebral fracture

Date issued: 2024
Language: English
Is part of: Journal of Neuromuscular Diseases (2024), Vol. 11, no. 1, p. 233-252
hdl: 1887/4209902
doi: 10.3233/JND-230176
URL: https://journals.sagepub.com/doi/10.3233/JND-230176